Chemoinformaics analysis of Nigakilactone-M,N,H,J,K,L
Molecular Weight | 424.49 | nRot | 2 |
Heavy Atom Molecular Weight | 392.234 | nRig | 22 |
Exact Molecular Weight | 424.21 | nRing | 4 |
Solubility: LogS | -2.217 | nHRing | 1 |
Solubility: LogP | 0.672 | No. of Aliphatic Rings | 4 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
Atoms Count | 62 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 30 | No. of Aromatic Carbocycles | 0 |
nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 22 | No. of Saturated Rings | 3 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 8 | No. of Arom Bond | 0 |
nHA | 8 | APOL | 64.4934 |
nHD | 3 | BPOL | 39.0466 |
QED | 0.55 |
Synth | 5.42 |
Natural Product Likeliness | 3.341 |
NR-PPAR-gamma | 0.011 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.996 |
Pgp-sub | 0.564 |
HIA | 0.752 |
CACO-2 | -4.922 |
MDCK | 0.0000245 |
BBB | 0.927 |
PPB | 0.417376 |
VDSS | 0.501 |
FU | 0.435261 |
CYP1A2-inh | 0.004 |
CYP1A2-sub | 0.388 |
CYP2c19-inh | 0.012 |
CYP2c19-sub | 0.825 |
CYP2c9-inh | 0.007 |
CYP2c9-sub | 0.064 |
CYP2d6-inh | 0.002 |
CYP2d6-sub | 0.129 |
CYP3a4-inh | 0.323 |
CYP3a4-sub | 0.672 |
CL | 4.049 |
T12 | 0.123 |
hERG | 0.027 |
Ames | 0.015 |
ROA | 0.613 |
SkinSen | 0.049 |
Carcinogencity | 0.085 |
EI | 0.006 |
Respiratory | 0.405 |
NR-Aromatase | 0.771 |
Antiviral | Yes |
Prediction | 0.681528 |